University Hospital Basel, Switzerland transfused first two COVID-19 patients with INTERCEPT treated Coronavirus convalescent plasma
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
Cerus announced inclusion of pathogen reduction technology in ISBT recommendations for preparation of COVID-19 convalescent plasma
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
Amgen and Adaptive Biotechnologies to develop a therapeutic to prevent or treat COVID-19
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
COVID-19 | Diagnostics | FDA
FDA approved Emergency IND Use of Humanigen’s lenzilumab for compassionate use in COVID-19 patients
On Apr. 2, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to the U.S….
Vanda Pharma announced initiation of FDA approved clinical study of Tradipitant patients with severe COVID-19 pneumonia
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
Biotechnology | COVID-19 | FDA | Therapeutics
Incyte initiated phase 3 clinical trial of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 cytokine storm
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
COVID-19 | Therapeutics | WHO
CHF Solutions doubled production staff of Aquadex SmartFlow consoles due to hospital demand
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
BioAegis accelerated multiple clinical trial submissions for severe COVID-19 pneumonia patients
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
Collaborative effort brings new COVID-19 treatment approach to Western New York
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
GW Hospital used VR technology to see into COVID-19 patientﾒs lungs
On Apr. 2, 2020, George Washington University Hospital announed it had used Virtual Reality technology to see into…
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
Philips enabled hospitals and GPs to remotely screen and monitor patients with COVID-19
On Apr. 1, 2020, Philips announced that it can help general practitioners and healthcare institutions manage the increased…
Innovation Pharma received data supporting Brilacidinﾒs direct inhibition of SARS-CoV-2
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinﾒs direct inhibition of SARS-CoV-2, the novel…
Henry Schein named exclusive distributor of second point-of-care antibody rapid test
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
Diffusion Pharma announced evaluating TSC against Acute Respiratory Distress Syndrome in COVID-19 patients
On Apr. 1, 2020, Diffusion Pharmaceuticals announced it had begun a cooperative research effort with University of Virginia…
Early study of COVID-19 patients showed high mortality rate
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
Vaxart provided update on its oral COVID-19 vaccine program
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidates
On Mar. 31, 2020, Sorrento announced it had entered into a research testing agreement with The University of…
Kleo Pharmaceuticals announced research collaboration with Green Cross LabCell to develop COVID-19-targeting allogeneic NK Cell combination therapy
On Mar. 31, 2020, Kleo Pharmaceuticals announced it had entered into a research collaboration with South Korea -based…
Mayo Clinic in Florida expanded specimen testing and processing capabilities for COVID-19
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
BD, BioMedomics announced launch of rapid serology test to detect exposure to COVID-19
On Mar. 31, 2020, BD (Becton, Dickinson and Company) and BioMedomics announced the release of a new point-of-care…
Chembio announced launch of DPP COVID-19 serological point-of-care test
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
VBI Vaccines announced collaboration with National Research Council of Canada to develop pan-Coronavirus vaccine candidate
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
Bellerophon Therapeutics announced first patient treated with INOpulse inhaled nitric oxide therapy for COVID-19
On Mar. 30, 2020, Bellerophon Therapeutics announced that expanded access treatment with the INOpulse inhaled nitric oxide system…
The USNS Comfort joined New York’s COVID-19 fight
On Mar. 30, 2020, the Military Sealift Command hospital ship USNS Comfort to join COVID-19 fight in New…
Bayer increased Germany’s COVID-19 analysis capacity by several thousand tests per day
On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its…
The Institute for Molecular Medicine in Finland launched a COVID-19 Host Genetics Initiative
On Mar. 30, 2020, the Institute for Molecular Medicine in Finland (FIMM) announced it had launched a COVID-19…
COVID-19 Therapeutics Accelerator awarded $20 million in initial grants to fund clinical trials
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…